These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10638206)

  • 21. Recent advances in factors that alter lipid metabolism in chronic renal failure.
    Drüeke T; Lacour B; Roullet JB; Funck-Brentano JL
    Kidney Int Suppl; 1983 Dec; 16():S134-8. PubMed ID: 6588243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
    Pac-Kozuchowska E
    Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Remnant hyperlipidemia and gene polymorphism].
    Tada N
    Nihon Rinsho; 1999 Dec; 57(12):2789-94. PubMed ID: 10638214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relevance of lipoprotein cholesterol levels measured by HPLC method to appearance midband on electrophoresis and remnant-like particle (RLP)-cholesterol levels].
    Kurosawa H; Doumitu K; Kobayashi M; Hirowatari Y; Yoshida H; Tada N
    Rinsho Byori; 2004 Sep; 52(9):737-41. PubMed ID: 15552933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
    Okamoto H; Miyai A; Sasase T; Furukawa N; Matsushita M; Nakano T; Nakajima K
    Clin Chim Acta; 2007 Jan; 375(1-2):92-8. PubMed ID: 16859664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipids, lipoproteins and apolipoproteins in normal newborns].
    Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
    Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.
    Karpe F; Taskinen MR; Nieminen MS; Frick MH; Kesäniemi YA; Pasternack A; Hamsten A; Syvänne M
    Atherosclerosis; 2001 Jul; 157(1):181-7. PubMed ID: 11427219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease.
    Devaraj S; Vega G; Lange R; Grundy SM; Jialal I
    Am J Med; 1998 May; 104(5):445-50. PubMed ID: 9626027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles.
    Inoue T; Saniabadi AR; Matsunaga R; Hoshi K; Yaguchi I; Morooka S
    Atherosclerosis; 1998 Aug; 139(2):363-7. PubMed ID: 9712343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyper-remnant-like particles (RLP) lipoproteinemia].
    Tanaka A; Ai M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():107-11. PubMed ID: 11347040
    [No Abstract]   [Full Text] [Related]  

  • 32. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study.
    McNamara JR; Shah PK; Nakajima K; Cupples LA; Wilson PW; Ordovas JM; Schaefer EJ
    Atherosclerosis; 2001 Jan; 154(1):229-36. PubMed ID: 11137104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal variation in serum remnant-like lipoproteins, platelet aggregation and fibrinolysis in healthy volunteers.
    Rydzewski A; Urano T; Nagai N; Takada Y; Katoh-Oishi Y; Taminato T; Yoshimi T; Takada A
    Haemostasis; 1997; 27(6):305-14. PubMed ID: 9731111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease.
    Hirany S; O'Byrne D; Devaraj S; Jialal I
    Clin Chem; 2000 May; 46(5):667-72. PubMed ID: 10794749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects.
    Schreuder PC; Twickler TB; Wang T; Nakajima K; Erkelens DW; Dallinga-Thie GM
    Atherosclerosis; 2001 Jul; 157(1):145-50. PubMed ID: 11427214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum.
    Kishi K; Ochiai K; Ohta Y; Uemura Y; Kanatani K; Nakajima K; Nakamura M
    Clin Chem; 2002 May; 48(5):737-41. PubMed ID: 11978600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro.
    Knöfler R; Nakano T; Nakajima K; Takada Y; Takada A
    Thromb Res; 1995 Apr; 78(2):161-71. PubMed ID: 7482433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia.
    Wang T; Nakajima K; Leary ET; Warnick GR; Cohn JS; Hopkins PN; Wu LL; Cilla DD; Zhong J; Havel RJ
    Clin Chem; 1999 Nov; 45(11):1981-7. PubMed ID: 10545069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipoprotein Z].
    Kajiyama G; Otsuki T; Kawanishi M
    Nihon Rinsho; 1994 Dec; 52(12):3084-9. PubMed ID: 7853693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Remnant-like particle-cholesterol (RLP-C)].
    Yamada N; Nakajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():26-9. PubMed ID: 15658254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.